ATE444493T1 - Verfahren zur identifikation von salzempfindlichen personen - Google Patents

Verfahren zur identifikation von salzempfindlichen personen

Info

Publication number
ATE444493T1
ATE444493T1 AT03764573T AT03764573T ATE444493T1 AT E444493 T1 ATE444493 T1 AT E444493T1 AT 03764573 T AT03764573 T AT 03764573T AT 03764573 T AT03764573 T AT 03764573T AT E444493 T1 ATE444493 T1 AT E444493T1
Authority
AT
Austria
Prior art keywords
salt
binding activity
sensitive persons
sensitivity
identifying salt
Prior art date
Application number
AT03764573T
Other languages
English (en)
Inventor
Myrtle Thierry-Palmer
Mohamed Bayorh
Akins Doherty
Keri Griffin
Original Assignee
Morehouse School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morehouse School Of Medicine filed Critical Morehouse School Of Medicine
Application granted granted Critical
Publication of ATE444493T1 publication Critical patent/ATE444493T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03764573T 2002-07-12 2003-07-11 Verfahren zur identifikation von salzempfindlichen personen ATE444493T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39545702P 2002-07-12 2002-07-12
PCT/US2003/021843 WO2004006844A2 (en) 2002-07-12 2003-07-11 Method for identifying salt-sensitive persons

Publications (1)

Publication Number Publication Date
ATE444493T1 true ATE444493T1 (de) 2009-10-15

Family

ID=30115875

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03764573T ATE444493T1 (de) 2002-07-12 2003-07-11 Verfahren zur identifikation von salzempfindlichen personen

Country Status (6)

Country Link
US (1) US7888000B2 (de)
EP (1) EP1534075B1 (de)
AT (1) ATE444493T1 (de)
AU (1) AU2003256515A1 (de)
DE (1) DE60329500D1 (de)
WO (1) WO2004006844A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2633324B1 (de) 2010-10-29 2018-11-21 Cohesive Technologies Inc. Lc-ms-konfiguration für die reinigung und den nachweis von analyten mit verschiedensten hydrophoben eigenschaften
WO2012058614A1 (en) * 2010-10-29 2012-05-03 Cohesive Technologies Inc. Lc-ms separation and detection of vitamin d metabolites

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3772150A (en) * 1971-12-29 1973-11-13 Us Health Process for producing vitamin d{11 {11 metabolite
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same
US4229359A (en) * 1979-09-04 1980-10-21 Wisconsin Alumni Research Foundation Derivatives of 25-hydroxycholecalciferol
US4883791A (en) * 1987-09-21 1989-11-28 Board Of Regents, The University Of Texas System 25S,26-dihydroxycholecalciferol in the treatment of hypercalcitriolemic disease states
US5202266A (en) 1987-10-14 1993-04-13 Asahi Kasei Kogyo Kabushiki Kaisha 25-hydroxy vitamin D3 derivatives, process for their production, and assay method using the same
WO1994026413A1 (en) * 1993-05-17 1994-11-24 Amersham International Plc Devices and methods for the measurement of cellular biochemical processes
GB9317193D0 (en) * 1993-08-18 1993-10-06 Zeneca Ltd Method
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
US5695794A (en) * 1995-08-10 1997-12-09 Amoco Corporation Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain
US6787660B1 (en) * 1998-06-25 2004-09-07 Immundiagnostik Ag Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1α, dihydroxy-vitamin D
US6610504B1 (en) * 2000-04-10 2003-08-26 General Atomics Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
GB0029729D0 (en) 2000-12-06 2001-01-17 Ids Ltd Method for detection of vitamin D metabolites
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay

Also Published As

Publication number Publication date
EP1534075A2 (de) 2005-06-01
AU2003256515A1 (en) 2004-02-02
AU2003256515A8 (en) 2004-02-02
WO2004006844A2 (en) 2004-01-22
DE60329500D1 (de) 2009-11-12
WO2004006844A3 (en) 2004-06-24
US20040072374A1 (en) 2004-04-15
EP1534075B1 (de) 2009-09-30
EP1534075A4 (de) 2007-05-09
US7888000B2 (en) 2011-02-15

Similar Documents

Publication Publication Date Title
DE60320101D1 (de) Verfahren für regressionsanalyse von formationsparametern
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE460668T1 (de) Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
AU2003278768A1 (en) Method and system for assessment of biomarkers by measurement of response to stimulus
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
NO20031624D0 (no) Galvanisk metode for måling av elektrisk anisotropi
DE60307617D1 (de) Verfahren zur gewinnung von gold
DE60229303D1 (de) Bioäquivalenztest für eisenhaltige formulierungen
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
WO2003076896A3 (en) Use of biomarkers to detect breast cancer
DE60329500D1 (de) Verfahren zur identifikation von salzempfindlichen personen
WO2005012901A3 (en) Method for measuring aromatase activity
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
ATE449380T1 (de) System und verfahren zur quantitativen anwendungsmessung
ATE519860T1 (de) Verwendung von ribozymen zur detektion ebenfalls vorhandener agenzien
DE50312755D1 (de) Verfahren zur Bestimmung des Verschleisses eines elektrochemischen Energiespeichers
ATE447610T1 (de) Kristalliner vap-1 und verwendung
DE602004005859D1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
FR2842305B1 (fr) Procede de determination de l'independance d'un systeme electrochimique
BRPI0514851A (pt) marcadores de polipeptìdio para o diagnóstico de arteriosclerose
DE60324348D1 (de) Verfahren zur Beurteilung der Empfindlichkeit der Haut
ATE364095T1 (de) Gtp cyclohydrolase ii als ziel für fungizide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties